Immunoproteasome-selective inhibitors: An overview of recent developments as potential drugs for hematologic malignancies and autoimmune diseases.
Sign Up to like & getrecommendations! Published in 2019 at "European journal of medicinal chemistry"
DOI: 10.1016/j.ejmech.2019.111646
Abstract: The immunoproteasome, a specialized form of proteasome, is mainly expressed in lymphocytes and monocytes of jawed vertebrates and responsible for the generation of antigenic peptides for cell-mediated immunity. Overexpression of immunoproteasome have been detected in… read more here.
Keywords: overview recent; inhibitors overview; recent developments; immunoproteasome selective ... See more keywords
EZH2, HIF-1, and Their Inhibitors: An Overview on Pediatric Cancers
Sign Up to like & getrecommendations! Published in 2018 at "Frontiers in Pediatrics"
DOI: 10.3389/fped.2018.00328
Abstract: During the past decades, several discoveries have established the role of epigenetic modifications and cellular microenvironment in tumor growth and progression. One of the main representatives concerning epigenetic modification is the polycomb group (PcG). It… read more here.
Keywords: tumor; inhibitors overview; ezh2 hif; overview pediatric ... See more keywords
Synthesis of Arginase Inhibitors: An Overview
Sign Up to like & getrecommendations! Published in 2025 at "Pharmaceutics"
DOI: 10.3390/pharmaceutics17010117
Abstract: Arginase (ARG) is a binuclear manganese-containing metalloenzyme that can convert L-arginine to L-ornithine and urea and plays a key role in the urea cycle. It also mediates different cellular functions and processes such as proliferation,… read more here.
Keywords: synthesis arginase; arginase; arginase inhibitors; arg arg ... See more keywords